D-Wave Quantum Advances Drug Discovery with JT Partnership
Company Announcements

D-Wave Quantum Advances Drug Discovery with JT Partnership

D-Wave Quantum ( (QBTS) ) has issued an update.

D-Wave Quantum Inc. and Japan Tobacco Inc.’s pharmaceutical division are teaming up to revolutionize drug discovery by integrating quantum computing and AI. Their joint proof-of-concept project is designed to enhance the speed and effectiveness of AI in identifying new ‘first-in-class’ small molecule pharmaceuticals. D-Wave’s expertise in quantum computing will be leveraged to expand the capabilities of JT’s AI systems, potentially setting a new standard in the pharmaceutical industry and accelerating the development of innovative drugs.

Find detailed analytics on QBTS stock on TipRanks’ Stock Analysis page.

Related Articles
Christine BrownQBTS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TipRanks Auto-Generated NewsdeskD-Wave Quantum Unveils Advanced 4,400+ Qubit Processor
TheFlyD-Wave regains compliance with NYSE continued listing standards
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App